|
2024
|
Invention
|
Bispecific or-gate chimeric antigen receptor responsive to cd20 and cd19. A CD20-OR-CD19 chimeric... |
|
2023
|
Invention
|
Detection and treatment of autoimmune disorders.
Disclosed herein are methods of treatment of au... |
|
|
Invention
|
Methods of use for car t cells. The present disclosure relates to methods of treating a patient w... |
|
|
Invention
|
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20. A CD19-OR-CD20 chimeric... |
|
|
Invention
|
Early intervention methods to prevent or ameliorate toxicity. Provided are methods for preventing... |
|
|
Invention
|
Bispecific chimeric antigen receptors, encoding polynucleotides and use of receptors thereof to t... |
|
|
Invention
|
Vaccine for falciparum malaria. The invention provides compositions and methods for preventing or... |
|
2022
|
Invention
|
Monocyte and macrophage binding aptamers and their application. Provided herein are compositions ... |
|
|
Invention
|
Methods of treating kawasaki disease. The present invention relates to the discovery that etanerc... |
|
2021
|
Invention
|
Drug regulated transgene expression. The present invention provides nucleic acids, vectors, host ... |
|
|
Invention
|
Disinfection method and apparatus. Photosensitizers are incorporated into articles, such a person... |
|
|
Invention
|
Antimicrobial preventive netting. An antimicrobial preventive netting is disclosed that includes ... |
|
|
Invention
|
Vaccine generation. An apparatus for vaccine generation includes a syringe with a cavity that inc... |
|
|
Invention
|
Proteomic screening for lysosomal storage diseases. Early detection of lysosomal storage diseases... |
|
|
Invention
|
Doubly attenuated late liver stage malaria parasites and related compositions and methods. The di... |
|
2020
|
Invention
|
Production of engineered t-cells by sleeping beauty transposon coupled with methotrexate selectio... |
|
|
Invention
|
Bispecific car t-cells for solid tumor targeting. Disclosed herein are methods of engineering a b... |
|
|
Invention
|
Bispecific chimeric antigen receptors, encoding polynucleotides thereof and methods of use thereo... |
|
|
Invention
|
Transgene genetic tags and methods of use. The present invention provides genetic tags operably l... |
|
2019
|
Invention
|
Genetic engineering of macrophages for immunotherapy. Disclosed are methods of making a genetical... |
|
|
Invention
|
Methods and compositions comprising b7h3 chimeric antigen receptors. Embodiments of the methods a... |
|
|
Invention
|
Detection and treatment of autoimmune disorders. Disclosed herein are methods of treatment of aut... |
|
|
Invention
|
Rapamycin resistant cells. The present application relates to, inter alia, compositions including... |
|
|
Invention
|
Expression of foxp3 in edited cd34+ cells. + cells. In some embodiments, guide RNA sequences that... |
|
|
Invention
|
Rescuing voltage-gated sodium channel function in inhibitory neurons. Selectively providing volta... |
|
|
Invention
|
Method for predicting progression to active tuberculosis disease. The invention provides a gene s... |
|
|
Invention
|
Sequencing method for car t cell therapy. The present disclosure relates to methods of treating a... |
|
|
Invention
|
Closed-system manufacturing process for car-t cells. Some embodiments provided herein relate to m... |
|
|
Invention
|
Fluorescein-specific cars exhibiting optimal t cell function against fl-ple labelled tumors. Aspe... |
|
|
Invention
|
Polynucleotides encoding bispecific chimeric antigen receptors. The invention is directed to a bi... |
|
2018
|
Invention
|
Anti-inflammatory coatings to improve biocompatibility of neurological implants. Neurological imp... |
|
|
Invention
|
Generating mammalian t cell activation inducible synthetic promoters (syn+pro) to improve t cell ... |
|
|
Invention
|
Homology directed repair compositions for the treatment of hemoglobinopathies. The present disclo... |
|
|
Invention
|
Therapeutic genome editing in wiskott-aldrich syndrome and x-linked thrombocytopenia. Described h... |
|
|
Invention
|
Phospholipid ether (ple) car t cell tumor targeting (ctct) agents. Aspects of the invention descr... |
|
2017
|
Invention
|
Methods of exogenous drug activation of chemical-induced signaling complexes expressed in enginee... |
|
|
Invention
|
Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of tra... |
|
2016
|
Invention
|
Biomarkers for prospective determination of risk for development of active tuberculosis. This inv... |
|
|
Invention
|
Method for treating autoimmune disease using cd4 t-cells with engineered stabilization of express... |
